PRESS RELEASE published on 02/29/2024 at 20:40, 2 years 8 months ago BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for financing of growth initiatives. The bonds have an interest rate of 6.52% p.a. and a maturity date of 5 September 2026 Financing Convertible Bond BRAIN Biotech AG Growth Initiatives EUR 5.0 Million
BRIEF published on 02/29/2024 at 20:11, 2 years 8 months ago BRAIN Biotech AG Announces Issuance of EUR 5 Million Convertible Bond Convertible Bonds Shareholder Rights Financial Strategy BRAIN Biotech AG Corporate Financing
BRIEF published on 02/29/2024 at 20:11, 2 years 8 months ago BRAIN Biotech AG annonce l'émission d'une obligation convertible de 5 millions d'euros Stratégie Financière BRAIN Biotech SA Liens Convertibles Financement D'entreprise Droits Des Actionnaires
PRESS RELEASE published on 02/29/2024 at 20:06, 2 years 8 months ago EQS-Adhoc: BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights BRAIN Biotech AG issues EUR 5 million convertible bond without subscription rights, to be issued on 5 March 2024. Bonds have 6.52% interest rate and due for repayment in 2026 Convertible Bond BRAIN Biotech AG Subscription Rights Interest Rate Repayment
BRIEF published on 02/28/2024 at 07:30, 2 years 8 months ago BRAIN Biotech AG : Bilan du premier trimestre de l'exercice 2023/24 Croissance Organique Rapport Financier BRAIN Biotech AG BioScience BioProduits
BRIEF published on 02/28/2024 at 07:30, 2 years 8 months ago BRAIN Biotech AG: Review of the first quarter of the 2023/24 financial year Financial Report Organic Growth BRAIN Biotech AG BioScience BioProducts
PRESS RELEASE published on 02/28/2024 at 07:30, 2 years 8 months ago 3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 BRAIN Biotech AG reports optimistic outlook for fiscal year 2023/24 with strong start in BioScience business. Quarterly report includes details on revenue and segment performance Revenue Growth Financial Performance BRAIN Biotech AG Fiscal Year 2023/24 BioScience Business
PRESS RELEASE published on 09/28/2023 at 10:30, 3 years 1 month ago BRAIN Biotech AG: BRAIN Biotech AG´s Akribion Genomics team wins first prize at the “BioRiver Boost!” startup competition
PRESS RELEASE published on 09/14/2023 at 10:30, 3 years 1 month ago BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®
PRESS RELEASE published on 09/12/2023 at 15:45, 3 years 1 month ago BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family
Published on 11/06/2026 at 05:15, 6 hours 44 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 00:53, 11 hours 6 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 11 hours 14 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/06/2026 at 11:44, 15 minutes ago Turkiye Garanti Bankasi A.S.: Daily Share Buyback Transactions
Published on 11/06/2026 at 11:41, 18 minutes ago Turkiye Garanti Bankasi A.S.: The Capital Increase of our Bank’s subsidiary Garanti Finansal Kiralama A.S
Published on 11/06/2026 at 11:38, 21 minutes ago Turkiye Garanti Bankasi A.S.: Daily Share Buyback Transactions
Published on 11/06/2026 at 11:35, 24 minutes ago Turkiye Garanti Bankasi A.S.: Announcement regarding the launch of a share buyback program
Published on 11/06/2026 at 11:31, 28 minutes ago Turkiye Garanti Bankasi A.S.: Completion of the Sale of Subsidiaries
Published on 11/06/2026 at 09:07, 2 hours 52 minutes ago Mise à disposition de la note d'information de M14 dans le cadre de l'OPR visant les actions BOURRELIER GROUP
Published on 11/06/2026 at 09:04, 2 hours 54 minutes ago Mise à disposition de la note d'information en réponse établie par BOURRELIER GROUP initiée par M14
Published on 11/05/2026 at 18:21, 17 hours 38 minutes ago Capital et droits de vote au 31 octobre 2026
